title: MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment.
abstract: In MHC class I-deficient hosts, natural killer (NK) cells are hyporesponsive to cross-linking of activation receptors. Functional competence requires engagement of a self-major histocompatability complex (MHC) class I-specific inhibitory receptor, a process referred to as "licensing." We previously suggested that licensing is developmentally determined in the bone marrow. In this study, we find that unlicensed mature MHC class I-deficient splenic NK cells show gain-of-function and acquire a licensed phenotype after adoptive transfer into wild-type (WT) hosts. Transferred NK cells produce WT levels of interferon-γ after engagement of multiple activation receptors, and degranulate at levels equivalent to WT NK cells upon coincubation with target cells. Only NK cells expressing an inhibitory Ly49 receptor specific for a cognate host MHC class I molecule show this gain-of-function. Therefore, these findings, which may be relevant to clinical bone marrow transplantation, suggest that neither exposure to MHC class I ligands during NK development in the BM nor endogenous MHC class I expression by NK cells themselves is absolutely required for licensing.
authors.affiliation: Division of Biology and Biomedical Sciences, Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA.
authors.forename: Julie M
authors.initials: JM
authors.lastname: Elliott
authors.forename: Joseph A
authors.initials: JA
authors.lastname: Wahle
authors.forename: Wayne M
authors.initials: WM
authors.lastname: Yokoyama
mesh_terms: D019264:Adoptive Transfer; D000818:Animals; D016026:Bone Marrow Transplantation; D002454:Cell Differentiation; D015395:Histocompatibility Antigens Class I / Q000276:immunology*; D007371:Interferon-gamma / Q000096:biosynthesis / Q000276:immunology; D007694:Killer Cells, Natural / Q000276:immunology* / Q000637:transplantation; D008213:Lymphocyte Activation / Q000276:immunology*; D051379:Mice; D008810:Mice, Inbred C57BL; D055650:NK Cell Lectin-Like Receptor Subfamily A / Q000096:biosynthesis / Q000276:immunology*; D014181:Transplantation Immunology
chemical_list: D015395:Histocompatibility Antigens Class I; D055650:NK Cell Lectin-Like Receptor Subfamily A; D007371:Interferon-gamma
references.citation: Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1915-9
references.pmid: 19181844
references.citation: Nat Rev Immunol. 2006 Jul;6(7):520-31
references.pmid: 16799471
references.citation: J Exp Med. 2007 Apr 16;204(4):853-63
references.pmid: 17420270
references.citation: J Immunol. 2007 Nov 1;179(9):5977-89
references.pmid: 17947671
references.citation: Biol Blood Marrow Transplant. 2005 Apr;11(4):252-9
references.pmid: 15812390
references.citation: J Exp Med. 2001 Nov 19;194(10):1519-30
references.pmid: 11714758
references.citation: J Exp Med. 2001 Nov 19;194(10):1531-9
references.pmid: 11714759
references.citation: Immunol Rev. 2008 Aug;224:85-97
references.pmid: 18759922
references.citation: J Immunol. 2008 Dec 1;181(11):7453-7
references.pmid: 19017932
references.citation: J Immunol. 1998 Dec 1;161(11):6133-8
references.pmid: 9834098
references.citation: Best Pract Res Clin Haematol. 2008 Sep;21(3):467-83
references.pmid: 18790450
references.citation: J Exp Med. 1971 Dec 1;134(6):1513-28
references.pmid: 4942407
references.citation: Nature. 1992 Jul 2;358(6381):66-70
references.pmid: 1614533
references.citation: Nature. 2005 Aug 4;436(7051):709-13
references.pmid: 16079848
references.citation: Nature. 1986 Feb 20-26;319(6055):675-8
references.pmid: 3951539
references.citation: PLoS Genet. 2005 Aug;1(2):129-39
references.pmid: 16132082
references.citation: Nature. 1991 Jan 24;349(6307):329-31
references.pmid: 1987491
references.citation: Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10332-6
references.pmid: 1946452
references.citation: Immunity. 2006 Aug;25(2):331-42
references.pmid: 16901727
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3053-8
references.pmid: 18287063
references.citation: Nat Rev Immunol. 2007 Sep;7(9):703-14
references.pmid: 17717540
references.citation: Eur J Immunol. 2007 Feb;37(2):516-27
references.pmid: 17236237
references.citation: Nature. 2009 Jan 29;457(7229):557-61
references.pmid: 19136945
references.citation: Nat Immunol. 2002 Jun;3(6):523-8
references.pmid: 12006976
references.citation: Immunity. 2009 Mar 20;30(3):337-47
references.pmid: 19249231
references.citation: J Exp Med. 2001 Nov 19;194(10):1507-17
references.pmid: 11714757
references.citation: Blood. 2005 Jun 1;105(11):4416-23
references.pmid: 15728129
references.citation: Annu Rev Immunol. 2006;24:257-86
references.pmid: 16551250